Asston Pharmaceuticals IPO is to open on July 9, 2025. It is a SME IPO that will raise ₹27.56 crores. The Asston Pharmaceuticals IPO price band is fixed at ₹115 to ₹123 with a market lot of 2000 Shares.
Asston Pharmaceuticals Limited was established in 2019 is one of the growing companies engaged in the business of pharmaceuticals, as well as involved in the exporting of the healthcare products globally. The company’s portfolio consists of wide range of products such as tablets, capsules, sachets, and syrups. The company offers various products in therapeutic categories include analgesics, antibiotics, antifungals, vitamins, and more. Asston pharmaceutical is involved in the manufacturing of pharmaceutical products for direct sales and also on a contract manufacturing or loan license basis mostly working on a principle-to-principle approach with various marketers. Asston pharmaceuticals ltd is FDA certified by both Central and State FDA, accredited by NQA (Nuclear Quality Assurance), and complies with Quality Management System (QMS) standards, ensuring high-quality manufacturing. The company’s portfolio consists of many products such as Albendazole USP 400 mg, Diclofenac 100 mg, Ibuprofen, paracetamol, and Ferrovit Syrup. The company includes 46 Permanent employees and 6 contractual employees as of 3 July, 2025.
Asston Pharmaceuticals IPO GMP Live Rates day by day with Kostak rates.
Date | IPO GMP | GMP Trend | Kostak | Subject to |
16 July | ₹32 |
![]() |
₹- | ₹31,500 |
15 July | ₹22 |
![]() |
₹- | ₹16,700 |
14 July | ₹30 |
![]() |
₹- | ₹22,800 |
12 July | ₹30 |
![]() |
₹- | ₹22,800 |
11 July | ₹30 |
![]() |
₹- | ₹22,800 |
10 July | ₹20 |
![]() |
₹- | ₹15,200 |
9 July | ₹15 |
![]() |
₹- | ₹11,400 |
8 July | ₹10 |
![]() |
₹- | ₹7,600 |
7 July | ₹10 |
![]() |
₹- | ₹7,600 |
5 July | ₹10 |
![]() |
₹- | ₹7,600 |
4 July | ₹- | – | ₹- | ₹- |
Asston Pharmaceuticals IPO Details
IPO Open Date: | July 9, 2025 |
IPO Close Date: | July 11, 2025 |
Face Value: | ₹10 Per Equity Share |
IPO Price Band: | ₹115 to ₹123 Per Share |
Issue Size: | Approx ₹27.56 Crores |
Fresh Issue: | Approx ₹27.56 Crores |
Issue Type: | Book Build Issue |
IPO Listing: | BSE SME |
Retail Quota: | Not more than 35% |
QIB Quota: | Not more than 50% |
NII Quota: | Not more than 15% |
DRHP Draft Prospectus: | Click Here |
RHP Draft Prospectus: | Click Here |
Anchor Investors List: | Click Here |
Asston Pharmaceuticals IPO Dates
IPO Open Date: | July 9, 2025 |
IPO Close Date: | July 11, 2025 |
Basis of Allotment: | July 14, 2025 |
Refunds: | July 15, 2025 |
Credit to Demat Account: | July 15, 2025 |
IPO Listing Date: | July 16, 2025 |
Asston Pharmaceuticals IPO GMP aka Grey Market Premium FAQs:
What is Asston Pharmaceuticals IPO GMP Today?
What is Asston Pharmaceuticals IPO Kostak Rate Today?
What is Asston Pharmaceuticals IPO Subject to Sauda Today?
What is Asston Pharmaceuticals IPO Expected Returns?
Disclaimer:
- IPO Grey Market Premium (Asston Pharmaceuticals IPO GMP) mention is valid for the specific date as mentioned in the header.
- We are not buying and selling IPO forms on IPO Grey Market.
- Kostak Rate is the premium one gets by selling his/her IPO application (in an off-market transaction) to someone else even before allotment or listing of the issue.
- Do not subscribe for IPO by just seeing the premium Price as it may change anytime before listing. Subscribe only considering the fundamentals of the companies.